Targeted Talks is a podcast series featuring one-on-one conversations with leading oncologists about the issues shaping cancer care today. Each episode explores the real-world challenges clinicians face alongside discussions of emerging research across tumor types. Whether unpacking new data, translating conference highlights into clinical context, or addressing the practical realities of oncology practice, Targeted Talks delivers timely, actionable conversations designed for today's oncology…
Subscribe:.rss.atom.json.md.m3u.pls
Live Last read · last published · next check
Saves to your Listen queue, to pick up on another day or another device.
In part 2 of this conversation, oncologists discuss how they help both patients and trainees navigate an overwhelming volume of medical information. The speakers describe encouraging patients to consult reliable resources like NCCN's patient site rather than turning solely to AI chatbots, while also acknowledging patients will inevitably seek outside information and clarification from family. For…
In this episode of Treating Together, host Dr Pallav Mehta sits down with Dr Kurt Demel and Dr Yan Ji, 2 community-based medical oncologists practicing in the Twin Cities, to tackle a problem every oncologist feels but few have named clearly: information overload. The conversation opens with a deceptively simple question: When does learning become overload? The group traces the line from the…
In this episode, managing editor Sabrina Serani sits down with 3 experts at the intersection of oncology pharmacy, health informatics, and drug distribution to unpack the 505(b)(2) regulatory pathway and what it means for cancer centers navigating today's complex drug landscape. Guests: Jessica White, PharmD, Vice President, Specialty Programs & Portfolio Management at McKesson Derek Burns,…
Ahead of the 2026 ASCO Annual Meeting, Sabrina Serani, managing editor of Targeted Oncology , previews the late-breaking abstracts most likely to influence clinical practice across breast, colorectal, prostate, and lung cancer, as well as in metastatic uveal melanoma, a disease that has gone without an effective systemic therapy for decades. From VIKTORIA-1 in PIK3CA- mutant metastatic breast…
In this episode of the Treating Together podcast, host Pallav Mehta, MD, medical oncologist at MD Anderson Cancer Center at Cooper University Health Care and medical director of Reimagine Care, speaks with E. Anders (Andy) Kolb, MD, president and chief executive officer of Blood Cancer United (formerly The Leukemia & Lymphoma Society; LLS). Together, they unpack the major forces shaping change in…
In this episode of Treating Together, host Marc Braunstein, MD, PhD, associate professor of medicine at the NYU Perlmutter Cancer Center, sits down with Adam Kittai, MD, associate professor and director of the CLL and Lymphoma programs at NYU Perlmutter Cancer Center, for a deep dive into the rapidly evolving frontline treatment landscape in chronic lymphocytic leukemia (CLL). As chemotherapy…
In this episode of Targeted Oncology’s Treating Together podcast, Dr Pallav Mehta sits down with Dr Sanjay Juneja, aka The Onc Doc, a medical oncologist known for his social media presence and his work in medical informatics. The duo explores how the landscape of cancer care is shifting from a "paucity of information" to a challenge of "information overload," and how technology can bridge the gap…
Dr Gabriel Mannis from Stanford University and Dr Gail Roboz from Weill Cornell Medicine discussed the evolving treatment landscape for relapsed/refractory NPM1-mutant acute myeloid leukemia (AML). The conversation highlighted the dramatic transformation of relapsed/refractory AML management from a space where "drugs went to die" to one with multiple targeted therapeutic options. Dr Roboz…
In this episode of the Treating Together podcast, host Dr Pallav Mehta, medical oncologist at MD Anderson Cancer Center at Cooper, assistant professor of medicine at Cooper Medical School, and medical director of Reimagine Care, sits down with Jorge Garcia, PharmD, founder of Patagonia Healthcare, for an in-depth conversation about the rapidly evolving landscape of advanced cancer therapies, from…
